<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Avigen from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Avigen news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 10:00:44 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Avigen" rel="self" type="application/rss+xml" />

	
<item><title>Avigen, Inc. - Financial And Strategic Analysis Review - New Report Published</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034417&amp;HITNO=0&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034417&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535781337%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034417&amp;HITNO=0&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034417&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535781337%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>OfficialWire:</description></item>
<item><title>Pharmacokinetics: Research conducted at Avigen, Inc. has provided new information about pharmacokinetics</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033259&amp;HITNO=1&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033259&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535088698%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033259&amp;HITNO=1&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033259&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535088698%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsRX:</description></item>
<item><title>Synageva BioPharma (formerly AviGenics, Inc.)-Company Report - new market report released</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016410&amp;HITNO=2&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016410&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524751454%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016410&amp;HITNO=2&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016410&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524751454%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>Avigen Inc-Therapeutic Competitors - new market report released</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4007773&amp;HITNO=3&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4007773&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521277795%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4007773&amp;HITNO=3&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4007773&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521277795%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>Avigen Inc.-Deals &amp; Alliances Report - new market report released</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4000547&amp;HITNO=4&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4000547&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518081518%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4000547&amp;HITNO=4&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4000547&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518081518%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>Avigen Inc-Detailed Product Pipeline - new market report released</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3994630&amp;HITNO=5&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3994630&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2515161401%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3994630&amp;HITNO=5&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3994630&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2515161401%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>MediciNova Appoints Dr. Kirk Johnson Chief Scientific Officer</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3991317&amp;HITNO=6&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3991317&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513659051%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3991317&amp;HITNO=6&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3991317&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513659051%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Stockhouse Canada:</description></item>
<item><title>MediciNova Appoints Dr. Kirk Johnson Chief Scientific Officer</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3991056&amp;HITNO=7&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3991056&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513546065%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3991056&amp;HITNO=7&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3991056&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513546065%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Interest!ALERT:</description></item>
<item><title>MediciNova Appoints Dr. Kirk Johnson Chief Scientific Officer</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990620&amp;HITNO=8&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990620&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513384309%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990620&amp;HITNO=8&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990620&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513384309%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>MediciNova Appoints Dr. Kirk Johnson Chief Scientific Officer - Z...</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990500&amp;HITNO=9&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990500&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513343263%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990500&amp;HITNO=9&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990500&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513343263%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Zibb:</description></item>
<item><title>MediciNova Appoints Dr. Kirk Johnson Chief Scientific Officer</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990340&amp;HITNO=10&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990340&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513278919%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990340&amp;HITNO=10&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990340&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513278919%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>MediciNova Appoints Dr. Kirk Johnson Chief Scientific Officer</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990244&amp;HITNO=11&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990244&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513217917%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990244&amp;HITNO=11&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990244&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513217917%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsBlaze:</description></item>
<item><title>MediciNova Extends Conversion Deadline to January 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3857812&amp;HITNO=12&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3857812&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2443024857%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3857812&amp;HITNO=12&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3857812&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2443024857%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>MediciNova Extends Conversion Deadline to January 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3857581&amp;HITNO=13&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3857581&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2442967484%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3857581&amp;HITNO=13&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3857581&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2442967484%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>DMN Newswire:</description></item>
<item><title>MediciNova Extends Conversion Deadline to January 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3857538&amp;HITNO=14&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3857538&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2442946409%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3857538&amp;HITNO=14&amp;MSIZE=25&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Avigen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3857538&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2442946409%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GlobeNewswire via MSN Money:</description></item>
</channel></rss>